ZLZhiguang Liu

Zhiguang Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhiguang Liu has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Hu

    Medical Research and Biometrics Center, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiovascular Diseases, Beijing, China

    2 shared publications
  • Lap Ah Tse

    JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, People's Republic of China

    2 shared publications
  • Biyan Wang

    Medical Research & Biometrics Center, National Clinical Research Centre for Cardiovascular Diseases, Fuwai Hospital, National Centre for Cardiovascular Diseases, Peking Union Medical College & Chinese Academy of Medical Sciences

    1 shared publication
  • Chao Ying

    School of Rehabilitation Medicine, Gannan Medical University, Ganzhou, Jiangxi, China

    1 shared publication
  • Deren Qiang

    Wujin District Center for Disease Control and Prevention, Changzhou 213022, China

    1 shared publication
  • Duong Mylinh

    Population Health Research Institute, McMaster University and Hamilton Health Sciences

    1 shared publication

Latest Publications

  • Serum metabolic markers for α-synucleinopathies conversion in isolated REM sleep behavior disorder: a prospective cohort study

    by Yajie Zang, Ting Wang, Hui Zhang, Yuan Li, Chao Ying, Yuan Yuan, Feilong Chen, Zhiguang Liu, Yanning Cai, Piu Chan, et al.


  • Open Access

    Association between Preserved Ratio Impaired Spirometry with mortality and long-term cardiovascular outcomes in Chinese adults

    by Mengya Li, Yang Li, Mengxin Chen, Duong Mylinh, Qiujing Cai, Biyan Wang, Sumathy Rangarajan, Kai You, Jiying Li, Salim Yusuf, et al.

    Background To examine the prevalence and characteristics of PRISm among Chinese individuals, as well as its association with future mortality and cardiovascular (CVD) outcomes. Methods This was a substudy of the Prospective Urban Rural Epidemiology (PURE) study, which recruited 40,279 individuals aged 35-70 years from 115 urban and rural communities in 12 provinces across China between 2005 and 2009. At baseline, participants were categorized into subgroups based on PRISm, airflow obstruction (AO), and normal spirometry. Follow-up was conducted every three years to obtain information on major cardiovascular events and mortality. Cox frailty proportional hazard regression was used to estimate the hazard ratios (HR) and 95% confidence interval (95%CI). Results The baseline prevalence rates of PRISm, AO and normal spirometry were 29.3%, 8.5%, and 62.2% respectively. Over a median follow-up period of 11.9 years, 2,214 deaths, with 773 attributed to CVD, and 3,507 major CVD events were observed. After adjusting for potential confounders, individuals with PRISm, comparing to those with normal spirometry, exhibited significantly elevated risks of all-cause mortality (HR 1.42, 95%CI [1.29, 1.58]), CVD mortality (HR 1.35, 95%CI [1.14, 1.60]), major CVD events (HR 1.16, 95%CI [1.07, 1.25]), myocardial infarction (HR 1.34, 95%CI [1.15,1.56]), and heart failure (HR 2.02, 95%CI [1.46, 2.79]). Conclusions PRISm, a frequently observed result in spirometry among the general Chinese population, exhibits a substantial association with long-term all-cause mortality, CVD mortality, major CVD events. Further investigation is warranted to comprehensively compared the underlying pathophysiologic connection between PRISm and CVD as well as mortality. What is already known on this topic PRISm is considered a transient state with higher transition rates to both normal and obstructive spirometry, often indicating progression to COPD, which is associated with increased respiratory symptoms, diminished quality of life, and a higher risk of cardiovascular events and all-cause mortality. Given the limited understanding of PRISm, there are several studies on the association between PRISm and health outcomes have been carried out in different populations since the concept of PRISm was introduced in 2014. Longitudinal studies based on population cohorts such as COPDGene, UK Biobank, Rotterdam, and NHLBI have shown that PRISm is associated with an increased risk of all-cause mortality and adverse cardiovascular outcomes, with similar results found in a study based on a Japanese population. Lung function differs substantially between races and regions. Most of the existing PRISm-related studies are based on populations in developed countries such as Europe and the United States, and the conclusions of these studies should not be directly generalized to East Asian populations, including China. Currently, there is only two studies based on a Japanese and Korean aimed at exploring the relationship between PRISm and all-cause mortality and adverse cardiovascular outcomes, but the sample size of these study is relatively small, and the statistical power of the conclusions is relatively limited. What this study adds This is the first longitudinal study examining the association of PRISm with the risk for all-cause mortality and adverse cardiovascular outcomes in a general Chinese population. The results showed that the prevalence of PRISm in the general Chinese population is 29.3%, which is significantly higher than previous studies. Compared to individuals with normal spirometry, the population with baseline PRISm had a significantly increased risk of all-cause mortality, CVD mortality, myocardial infarction (MI), and heart failure (HF), and showed a trend towards higher risk than those with baseline airflow obstruction (AO, although no statistically significant difference was observed). How this study might affect research, practice or policy Our findings support that the early prevention, diagnosis, and intervention of PRISm may offer an important strategy to alleviating the high CVD burden in China.

  • Open Access

    Interaction of Depression and Unhealthy Diets on the Risk of Cardiovascular Diseases and All-Cause Mortality in the Chinese Population: A PURE Cohort Substudy

    by Xinyue Lang, Zhiguang Liu, Shofiqul Islam, Guoliang Han, Sumathy Rangarajan, Lap Ah Tse, Maha Mushtaha, Junying Wang, Lihua Hu, Deren Qiang, et al.

    This study aimed to identify the interaction of depression and diets on cardiovascular diseases (CVD) incident and death in China and key subpopulations. We included 40,925 participants from the Prospective Urban Rural Epidemiology (PURE)-China cohort which recruited participants aged 35–70 years from 45 urban and 70 rural communities. Depression was measured by the adapted Short-Form (CIDI-SF). The unhealthy diet was considered when the score of Alternative Healthy Eating Index was below the lowest tertile. The primary outcome was a composite outcome of incident CVD and all-cause mortality. Cox frailty models were used to examine the associations. During a median follow-up of 11.9 years (IQR: 9.6–12.6 years), depression significantly increased the risk of the composite outcome (HR = 2.00; 95% CI, 1.16–3.27), major CVD (HR = 1.82; 95% CI, 1.48–2.23), and all-cause mortality (HR = 2.21; 95% CI, 1.51–3.24) for the unhealthy diet group, but not for the healthy diet group. The interaction between depression and diet for the composite outcome was statistically significant (RERI = 1.19; 95% CI, 0.66–1.72; AP = 0.42, 95% CI, 0.27–0.61; SI = 3.30, 95% CI, 1.42–7.66; multiplicative-scale = 1.74 95% CI, 1.27–2.39), even in the subgroup and sensitivity analyses. In addition, the intake of vegetable and polyunsaturated fatty acids contributed most to the interaction of diets and depression. Depressive participants should focus on healthy diets, especially vegetables and polyunsaturated fatty acids, to avoid premature death and CVD.